Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis

被引:1
|
作者
Cucurella, MG
Rovira, A
Río, J
Pedraza, S
Tintoré, MM
Montalban, X
Alonso, J
机构
[1] Inst Diagnost Imatge, Ctr Vall Hebron, Unitat Ressonancia Magnet, Barcelona 08035, Spain
[2] Hosp Gen & Univ Vall Hebron, Dept Radiol, Barcelona 08035, Spain
[3] Inst Diagnost Imatge, Ctr Vall Hebron, Unitat Neuroinvest Clin, Barcelona 08035, Spain
关键词
nuclear magnetic resonance; H-1; NMR; human brain; multiple sclerosis;
D O I
10.1002/(SICI)1099-1492(200004)13:2<57::AID-NBM609>3.0.CO;2-5
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
The objective of this study was to characterize and compare the proton magnetic resonance spectrum of a voxel, containing lesions or normal-appearing white matter (NAWM), in primary-progressive (PP) and secondary-progressive (SP) multiple sclerosis (MS) patients. Single-voxel proton magnetic resonance spectroscopy and magnetic resonance imaging were performed in 35 MS patients (17 PP and 18 SP) and 17 controls. Spectra from an 8 ml voxel located in the parieto-occipital region were obtained with a spin-echo pulse sequence (1600 ms/135 ms/256, TR/TE/acquisitions). Resonance areas due to N-acetylaspartate (NAA), creatine/phosphocreatine (Cr) and choline compounds (Cho) were determined, and results expressed in terms of area in arbitrary units or as metabolite ratios. With respect to the control group, there were significant reductions in NAA and NAA/Cho ratio in the PP-lesion, SP-lesion, PP-NAWM and SP-NAWM groups. There were no significant differences between the PP-NAWM and SP-NAWM groups. These results support the existence of metabolic changes in the white matter of PP and SP patients and suggest that there is neuronal damage and/or loss in both clinical courses. Finally, characterization of the parieto-occipital region showed no significant differences in the spectral pattern of NAWM between PP and SP clinical courses of MS. Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:57 / 63
页数:7
相关论文
共 50 条
  • [21] Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
    Harding-Forrester, Sam
    Roos, Izanne
    Sharmin, Sifat
    Diouf, Ibrahima
    Malpas, Charles
    Nguyen, Ai-Lan
    Moradi, Nahid
    Horakova, Dana
    Havrdova, Eva Kubala
    Patti, Francesco
    Ayuso, Guillermo Izquierdo
    Madueno, Sara Eichau
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Grand'Maison, Francois
    Weinstock-Guttman, Bianca
    Amato, Maria Pia
    Grammond, Pierre
    Gerlach, Oliver
    Ozakbas, Serkan
    Sola, Patrizia
    Ferraro, Diana
    Butzkueven, Helmut
    Lechner-Scott, Jeannette
    Boz, Cavit
    Alroughani, Raed
    Van Pesch, Vincent
    Cartechini, Elisabetta
    Terzi, Murat
    Maimone, Davide
    Ramo-Tello, Cristina
    Spitaleri, Daniele Litterio A.
    Kappos, Ludwig
    Yamout, Bassem
    Sa, Maria Jose
    Slee, Mark
    Morgado, Yolanda Blanco
    Bergamaschi, Roberto
    Butler, Ernest
    Iuliano, Gerardo
    Granella, Franco
    Sidhom, Youssef
    Gouider, Riadh
    Ampapa, Radek
    Van Wijmeersch, Bart
    Karabudak, Rana
    Prevost, Julie
    NEUROLOGY, 2021, 96 (15)
  • [22] Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis
    Gouveia, A.
    Dias, S. P.
    Santos, T.
    Rocha, H.
    Coelho, C. R.
    Ruano, L.
    Galego, O.
    Diogo, M. C.
    Seixas, D.
    Sa, M. J.
    Batista, S.
    ACTA NEUROLOGICA SCANDINAVICA, 2017, 136 (02): : 109 - 115
  • [23] Differentiation of relapsing-remitting and secondary progressive multiple sclerosis: a magnetic resonance spectroscopy study based on machine learning
    Eksi, Ziya
    Cakiroglu, Murat
    Oz, Cemil
    Aralasmak, Ayse
    Karadeli, Hasan Huseyin
    Ozcan, Muhammed Emin
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2020, 78 (12) : 789 - 796
  • [24] Apparent diffusion coefficients in benign and secondary progressive multiple sclerosis by nuclear magnetic resonance
    Horsfield, MA
    Lai, M
    Webb, SL
    Barker, GJ
    Tofts, PS
    Turner, R
    Rudge, P
    Miller, DH
    MAGNETIC RESONANCE IN MEDICINE, 1996, 36 (03) : 393 - 400
  • [25] 1H magnetic resonance spectroscopy of normal-appearing white matter in primary progressive multiple sclerosis
    Leary, SM
    Davie, CA
    Parker, GJM
    MacManus, DG
    Miller, DH
    Thompson, AJ
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 464 - 464
  • [26] Disability accrual in primary and secondary progressive multiple sclerosis
    Harding-Forrester, Sam
    Roos, Izanne
    Nguyen, Ai-Lan
    Malpas, Charles B.
    Diouf, Ibrahima
    Moradi, Nahid
    Sharmin, Sifat
    Izquierdo, Guillermo
    Eichau, Sara
    Patti, Francesco
    Horakova, Dana
    Kubala Havrdova, Eva
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Maison, Francois Grand
    Onofrj, Marco
    Lugaresi, Alessandra
    Grammond, Pierre
    Ozakbas, Serkan
    Amato, Maria Pia
    Gerlach, Oliver
    Sola, Patrizia
    Ferraro, Diana
    Buzzard, Katherine
    Skibina, Olga
    Lechner-Scott, Jeannette
    Alroughani, Raed
    Boz, Cavit
    Van Pesch, Vincent
    Cartechini, Elisabetta
    Terzi, Murat
    Maimone, Davide
    Ramo-Tello, Cristina
    Yamout, Bassem
    Khoury, Samia Joseph
    La Spitaleri, Daniele
    Sa, Maria Jose
    Blanco, Yolanda
    Granella, Franco
    Slee, Mark
    Butler, Ernest
    Sidhom, Youssef
    Gouider, Riadh
    Bergamaschi, Roberto
    Karabudak, Rana
    Ampapa, Radek
    Sanchez-Menoyo, Jose Luis
    Prevost, Julie
    Castillo-Trivino, Tamara
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (09): : 707 - 717
  • [27] Cognitive impairment in primary and secondary progressive multiple sclerosis
    Wachowius, U
    Talley, M
    Silver, N
    Heinze, HJ
    Sailer, M
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2005, 27 (01) : 65 - 77
  • [28] Proton magnetic resonance spectroscopy in primary blepharospasm
    Federico, F
    Simone, IL
    Lucivero, V
    Defazio, G
    De Salvia, R
    Mezzapesa, DM
    Petruzzellis, M
    Tortorella, C
    Livrea, P
    NEUROLOGY, 1998, 51 (03) : 892 - 895
  • [29] Oral Masitinib in Patients with Primary Progressive or Secondary Progressive Multiple Sclerosis
    Vermersch, Patrick
    Benrabah, Rabah
    Schmidt, Nicolas
    Zephir, Helene
    Chen, Pierre
    Vongsouthi, Cyrille
    Moussy, Alain
    Hermine, Olivier
    NEUROLOGY, 2009, 72 (11) : A313 - A314
  • [30] Which one is more progressive; Primary, or Secondary Progressive Multiple Sclerosis?
    Ozcelik, Sinem
    Kaya, Ergi
    Ozdogar, Asiye Tuba
    Ozakbas, Serkan
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1247 - 1248